The US Government will now pick up the cost of weight loss drugs offered through the Medicare GLP-1 Bridge scheme until 31 December 2027.
This Durham-based facility will be AbbVie’s first manufacturing site in the state.
The initiative will combine MSD’s scientific and data expertise with Google Cloud’s AI and cloud technology.
According to GlobalData's high-prescriber survey, approximately 40% of LA HNSCC patients receive definitive chemoradiotherapy without surgery.
The MSD and Novo Holdings-backed Series B will shed light on the potential of Ray’s vision restoration treatment pipeline.
The decision is supported by one-year data from the PETITE-T1D Phase IV study evaluating Tzield in children.
